These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33363346)

  • 21. Oral immunization with an attenuated
    Hajam IA; Kirthika P; Hewawaduge C; Jawalagatti V; Park S; Senevirathne A; Lee JH
    Avian Pathol; 2020 Oct; 49(5):486-495. PubMed ID: 32483989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine Efficacy Against a New Avian Influenza (H9N2) Field Isolate from the Middle East (Serology and Challenge Studies).
    Gharaibeh S; Amareen S
    Avian Dis; 2015 Dec; 59(4):508-11. PubMed ID: 26629624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Single Vaccination of Chimeric Bivalent Virus-Like Particle Vaccine Confers Protection Against H9N2 and H3N2 Avian Influenza in Commercial Broilers and Allows a Strategy of Differentiating Infected from Vaccinated Animals.
    Sun YX; Li ZR; Zhang PJ; Han JH; Di HY; Qin JY; Cong YL
    Front Immunol; 2022; 13():902515. PubMed ID: 35874682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancing immunogenicity and protective efficacy of inactivated avian influenza H9N2vaccine with recombinant chicken IFN-α in chicken.
    Gan L; Tian Y; Zhao Y; Shan XQ; Zhou W; Xia BB; Chen J; Wang ML; Zhao J
    Vet Microbiol; 2019 Jul; 234():77-82. PubMed ID: 31213275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Immune Response Against Inactivated Avian Influenza (H9N2) Vaccine, by Using Chitosan Nanoparticles.
    Khalili I; Ghadimipour R; Sadigh Eteghad S; Fathi Najafi M; Ebrahimi MM; Godsian N; Sefidi Heris Y; Khalili MT
    Jundishapur J Microbiol; 2015 Dec; 8(12):e27035. PubMed ID: 26865942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative immune response and pathogenicity of the H9N2 avian influenza virus after administration of Immulant
    Eladl AH; Arafat N; El-Shafei RA; Farag VM; Saleh RM; Awadin WF
    Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():165-175. PubMed ID: 31300109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines.
    Stone H; Mitchell B; Brugh M
    Avian Dis; 1997; 41(4):856-63. PubMed ID: 9454919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivated H9N2 avian influenza virus vaccine with gel-primed and mineral oil-boosted regimen could produce improved immune response in broiler breeders.
    Lee DH; Kwon JS; Lee HJ; Lee YN; Hur W; Hong YH; Lee JB; Park SY; Choi IS; Song CS
    Poult Sci; 2011 May; 90(5):1020-2. PubMed ID: 21489949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection and differentiation of infected from vaccinated animals by an inactivated recombinant Newcastle disease virus/avian influenza H5 vaccine.
    Lozano-Dubernard B; Soto-Priante E; Sarfati-Mizrahi D; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
    Avian Dis; 2010 Mar; 54(1 Suppl):242-5. PubMed ID: 20521639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Newcastle disease and infectious bronchitis live vaccines on the immune system and production parameters of experimentally infected broiler chickens with H9N2 avian influenza.
    Amanollahi R; Asasi K; Abdi-Hachesoo B
    Comp Immunol Microbiol Infect Dis; 2020 May; 71():101492. PubMed ID: 32417570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the immuno-stimulatory effect of aqueous neem (Azadirachta indica) leaf extract against highly pathogenic avian influenza (H5N8) in experimental chickens.
    Hegazy AM; Hassanin O; Hemele MAM; Momenah MA; Al-Saeed FA; Shakak AO; El-Tarabily KA; El-Saadony MT; Tolba HMN
    Poult Sci; 2023 Nov; 102(11):103043. PubMed ID: 37741118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of autogenous and commercial H9N2 avian influenza vaccines in a challenge with recent dominant virus.
    Fallah Mehrabadi MH; Ghalyanchilangeroudi A; Ghafouri SA; Hosseini H; Zabihi Petroudi MT; Modiri Hamadan A; Rezaee H; Motamed Chaboki P; Vatandour S; Shayeganmehr A
    Iran J Vet Res; 2020; 21(2):109-114. PubMed ID: 32849889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvanticity of epimedium polysaccharide-propolis flavone on inactivated vaccines against AI and ND virus.
    Fan Y; Wang D; Liu J; Hu Y; Zhao X; Han G; Nguyen TL; Chang S
    Int J Biol Macromol; 2012 Dec; 51(5):1028-32. PubMed ID: 22935524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimeric Newcastle Disease Virus-like Particles Containing DC-Binding Peptide-Fused Haemagglutinin Protect Chickens from Virulent Newcastle Disease Virus and H9N2 Avian Influenza Virus Challenge.
    Xu X; Qian J; Qin L; Li J; Xue C; Ding J; Wang W; Ding W; Yin R; Jin N; Ding Z
    Virol Sin; 2020 Aug; 35(4):455-467. PubMed ID: 32274680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective efficacy of inactivated Newcastle disease virus vaccines prepared in two different oil-based adjuvants.
    Aljumaili OA; Bello MB; Yeap SK; Omar AR; Ideris A
    Onderstepoort J Vet Res; 2020 Sep; 87(1):e1-e7. PubMed ID: 33054260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals.
    Lee DH; Park JK; Lee YN; Song JM; Kang SM; Lee JB; Park SY; Choi IS; Song CS
    Vaccine; 2011 May; 29(23):4003-7. PubMed ID: 21463681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant Newcastle disease virus expressing H9 HA protects chickens against heterologous avian influenza H9N2 virus challenge.
    Nagy A; Lee J; Mena I; Henningson J; Li Y; Ma J; Duff M; Li Y; Lang Y; Yang J; Abdallah F; Richt J; Ali A; García-Sastre A; Ma W
    Vaccine; 2016 May; 34(23):2537-45. PubMed ID: 27102817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
    Kim SH; Samal SK
    Vaccine; 2017 Jul; 35(33):4133-4139. PubMed ID: 28668574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of protection and viral shedding following vaccination with Newcastle disease virus strains of different genotypes used in vaccine formulation.
    Wajid A; Basharat A; Bibi T; Rehmani SF
    Trop Anim Health Prod; 2018 Oct; 50(7):1645-1651. PubMed ID: 29728823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.